Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:13 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 37,997,522 8.54% | 2,369,731 (+6.65%) | View |
| 2024-02-13 10:17 am Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | GENERAL ATLANTIC L.P. | 26,259,141 5.6% | 14,400 (+0.05%) | View |
| 2024-02-09 3:13 pm Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | MORGAN STANLEY MS | 41,159,749 9.2% | -2,615,649 (-5.98%) | View |
| 2024-02-09 09:49 am Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 31,583,926 7.099% | -12,526,439 (-28.40%) | View |
| 2023-02-13 4:53 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | GENERAL ATLANTIC L.P. | 26,244,741 5.6% | 871 (+0.00%) | View |
| 2023-02-10 3:21 pm Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | MORGAN STANLEY MS | 43,775,398 9.9% | -12,235,612 (-21.85%) | View |
| 2023-02-09 12:31 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 44,110,365 9.999% | 22,030,570 (+99.78%) | View |
| 2023-02-09 11:32 am Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 35,627,791 8.08% | 5,991,226 (+20.22%) | View |
| 2023-02-09 11:06 am Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,000,000 1.59% | -17,842,715 (-71.82%) | View |
| 2022-10-04 4:30 pm Sale | 13D | ROYALTY PHARMA PLC SHS RPRX | Giuliani Mario Germano | 43,816,170 10% | -2,500,000 (-5.40%) | View |
| 2022-08-11 08:30 am Unchanged | 13D | ROYALTY PHARMA PLC SHS RPRX | Giuliani Mario Germano | 46,316,170 10.6% | 0 (Unchanged) | View |
| 2022-04-05 4:01 pm Unchanged | 13D | ROYALTY PHARMA PLC SHS RPRX | Giuliani Mario Germano | 46,316,170 10.7% | 0 (Unchanged) | View |
| 2022-02-10 4:43 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | MORGAN STANLEY MS | 56,011,010 13% | 9,866,127 (+21.38%) | View |
| 2022-02-10 10:44 am Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 24,842,715 5.78% | -13,871,565 (-35.83%) | View |
| 2022-02-10 08:37 am Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 29,636,565 6.9% | 29,636,565 (New Position) | View |
| 2022-02-09 10:24 am Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | FMR LLC | 22,079,795 5.14% | -2,862,750 (-11.48%) | View |
| 2021-02-12 7:11 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | GENERAL ATLANTIC L.P. | 26,243,870 6.4% | 26,243,870 (New Position) | View |
| 2021-02-11 07:52 am Sale | 13G | ROYALTY PHARMA PLC SHS RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 38,714,280 9.97% | -7,301,050 (-15.87%) | View |
| 2021-02-10 4:05 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | MORGAN STANLEY MS | 46,144,883 11.9% | 22,547,596 (+95.55%) | View |
| 2021-02-09 4:53 pm Purchase | 13G | ROYALTY PHARMA PLC SHS RPRX | MORGAN STANLEY MS | 23,597,287 6.1% | 23,597,287 (New Position) | View |